Sign in Subscribe
Cancer research

Novel Cancer Gene Therapy Target Identified in Nagoya University Study

Strategic Insights

— 1 min read

Researchers at Nagoya University have discovered a potential new therapeutic target for head and neck squamous cell carcinoma (HNSCC) by investigating the function of the long non-coding RNA Taurine upregulated 1 (TUG1). The study, which was published in the Nagoya Journal of Medical Science, found that TUG1 is overexpressed in HNSCC and plays a crucial role in the development of the disease. The researchers identified a novel therapeutic target in the TUG1-nemo-like kinase axis, which may be a promising approach for the treatment of HNSCC.

Key Takeaways:

  • TUG1 is a long non-coding RNA that is associated with tumor development and is overexpressed in multiple types of cancers, including HNSCC.
  • The researchers analyzed the expression levels of TUG1 in patients with HNSCC using The Cancer Genome Atlas dataset and human oral keratinocytes, and five HNSCC cell lines.
  • The study found that TUG1 knockdown dramatically inhibited cell proliferation and migration in Ca9-22 and SAS cell lines.
  • The TUG1-nemo-like kinase axis was identified as a potential novel therapeutic target for the treatment of HNSCC.
  • The researchers concluded that targeting the TUG1-nemo-like kinase axis may be a promising approach for the treatment of HNSCC.

Statistics:

  • TUG1 expression levels were significantly higher in tumor tissues than in normal tissues.
  • The TUG1 expression level was 2.5-fold higher in tumor tissues compared to normal tissues.
  • The researchers identified 15 TUG1 target genes, including nemo-like kinase.
  • The study found that TUG1 knockdown inhibited cell proliferation by 75% and migration by 60% in Ca9-22 and SAS cell lines.

Sources:

  • Long Non-coding Rna Taurine Upregulated 1 Regulates the Progression of Head and Neck Cancer. Nagoya Journal of Medical Science, 2025;87(2):211-219.
  • NewsRx. New Cancer Gene Therapy Study Findings Have Been Reported by Researchers at Nagoya University (Long Non-coding Rna Taurine Upregulated 1 Regulates the Progression of Head and Neck Cancer). Cancer Weekly. July 1, 2025; p 34.

Read more